Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Humoral immune response of BBIBP COVID‐19 vaccination before and after the booster immunization
Zhangkai J. Cheng, Huimin Huang, Peiyan Zheng, et al.
Allergy (2022) Vol. 77, Iss. 8, pp. 2404-2414
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Heterologous booster with inhaled adenovirus vector COVID-19 vaccine generated more neutralizing antibodies against different SARS-CoV-2 variants
Jiaying Zhong, Shuo Liu, Tingting Cui, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2689-2697
Open Access | Times Cited: 27
Dynamic Changes and Trends of SARS‐CoV‐2 Antibodies Induced by Infection and Vaccination Across Multiple Time Points
S.P. Zhang, Xiaoxiao Kong, Qian Zhen, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 1
Open Access
Waning neutralizing antibodies through 180 days after homologous and heterologous boosters of inactivated COVID-19 vaccine
Zhifei Chen, Fangqin Xie, Hairong Zhang, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
Characterization of stability, safety and immunogenicity of the mRNA lipid nanoparticle vaccine Iribovax® against COVID-19 in nonhuman primates
Parvin Zamani, Mohammad Mashreghi, Mahere Rezazade Bazaz, et al.
Journal of Controlled Release (2023) Vol. 360, pp. 316-334
Closed Access | Times Cited: 13
Immunogenicity Following Two Doses of the BBIBP-CorV Vaccine and a Third Booster Dose with a Viral Vector and mRNA COVID-19 Vaccines against Delta and Omicron Variants in Prime Immunized Adults with Two Doses of the BBIBP-CorV Vaccine
Jira Chansaenroj, Nungruthai Suntronwong, Sitthichai Kanokudom, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1071-1071
Open Access | Times Cited: 19
Immunogenicity and immune-persistence of the CoronaVac or Covilo inactivated COVID-19 Vaccine: a 6-month population-based cohort study
Qianhui Hua, Hangjie Zhang, Pingping Yao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Review of therapeutic mechanisms and applications based on SARS-CoV-2 neutralizing antibodies
Mingtao Liu, Hui Gan, Zhiman Liang, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 11
Antibody Response after Homologous and Heterologous Prime–Boost COVID-19 Vaccination in a Bangladeshi Residential University Cohort
Nihad Adnan, Md. Ahsanul Haq, Salma Akter, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 482-482
Open Access | Times Cited: 2
Protective effectiveness of previous infection against subsequent SARS-Cov-2 infection: systematic review and meta-analysis
Weihua Hu, Huanle Cai, Huan-Chang Yan, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 2
Evaluation of antibody kinetics and durability in healthy individuals vaccinated with inactivated COVID-19 vaccine (CoronaVac): A cross-sectional and cohort study in Zhejiang, China
Hangjie Zhang, Qianhui Hua, Nani Xu, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 7
Neutralizing antibody levels associated with injectable and aerosolized Ad5-nCoV boosters and BA.2 infection
Fuzhen Wang, Baoying Huang, Yao Deng, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Longitudinal study of humoral immunity against SARS-CoV-2 of health professionals in Brazil: the impact of booster dose and reinfection on antibody dynamics
Ana Paula Moreira Franco-Luiz, Núbia Monteiro Gonçalves Soares Fernandes, Thaís Bárbara de Souza Silva, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Exploring the Willingness of the COVID-19 Vaccine Booster Shots in China Using the Health Belief Model: Web-Based Online Cross-Sectional Study
Dehua Hu, Zhisheng Liu, Liyue Gong, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1336-1336
Open Access | Times Cited: 11
The immunogenicity of Alum+CpG adjuvant SARS-CoV-2 inactivated vaccine in mice
Jie Yang, Boran Li, Dongsheng Yang, et al.
Vaccine (2023) Vol. 41, Iss. 41, pp. 6064-6071
Closed Access | Times Cited: 6
Association between levels of IgG antibodies from vaccines and Omicron symptomatic infection among children and adolescents in China
Xinying Chen, Junbin Hong, Li-Jun Deng, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 6
Neutralizing Antibody Response to BBIBP-CorV in Comparison with COVID-19 Recovered, Unvaccinated Individuals in a Sample of the Pakistani Population
Javeria Aijaz, Shakir Hussain, Fouzia Naseer, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 692-692
Open Access | Times Cited: 10
Immunogenicity following two doses of BBIBP-CorV vaccine and a third booster dose with viral vector and Mrna COVID-19 vaccines against delta and omicron variants in prime immunized adults with two doses of BBIBP-CorV vaccine
Jira Chansaenroj, Nungruthai Suntronwong, Sitthichai Kanokudom, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 10
Mix-and-match COVID-19 vaccines trigger high antibody response after the third dose vaccine in Moroccan health care workers
Houda Amellal, Najlaa Assaid, Khadija Akarid, et al.
Vaccine X (2023) Vol. 14, pp. 100288-100288
Open Access | Times Cited: 5
Nanovaccines for Advancing Long-Lasting Immunity against Infectious Diseases
Xinglong Gao, Xinlian Wang, Shilin Li, et al.
ACS Nano (2023) Vol. 17, Iss. 24, pp. 24514-24538
Closed Access | Times Cited: 5
Antibody response to different COVID-19 vaccine regimes: a review
Tamires Cardoso Matsui, Amanda Campelo Lima de Melo, Maria da Conceição Rodrigues Fernandes, et al.
Brazilian Journal of Health Review (2024) Vol. 7, Iss. 1, pp. 488-506
Open Access | Times Cited: 1
COVID-19 antibody responses in individuals with natural immunity and with vaccination-induced immunity: a systematic review and meta-analysis
Qiuying Zhang, Lirui Jiao, Qiushi Chen, et al.
Systematic Reviews (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
The BBIBP-CorV inactivated COVID-19 vaccine induces robust and persistent humoral responses to SARS-CoV-2 nucleocapsid, besides spike protein in healthy adults
Qinjin Wang, Jie Ning, Ying Chen, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 8
Kinetics of SARS-CoV-2 neutralizing antibodies in Omicron breakthrough cases with inactivated vaccination: Role in inferring the history and duration of infection
Aidibai Simayi, Chuchu Li, Cong Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Homologous booster immunization with an inactivated vaccine induced robust antibody response in healthcare workers: A retrospective study
Gui-Ping Wen, Min Zhu, Lirong Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top